Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the Technology?
Background to the debate: In the United States, the passage of the Bayh–Dole Act in 1980 encouraged universities to license inventions for commercial development. Although this financial incentive can stimulate academic researchers to discover new drugs and devices, there is concern that the possibi...
Na minha lista:
| Publicado no: | PLoS Med |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
PLOS
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC545202/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15696219/ https://ncbi.nlm.nih.govhttps://doi.org/10.1371/journal.pmed.0020009 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|